Avigen to Present At Needham and Company Biotechnology Conference
June 07, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., June 7, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for chronic neurological care, announced today that President and CEO...
Avigen to Present at BIO 2007 International Convention
May 01, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., May 1, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, announced...
Avigen Announces Pricing of Common Stock Offering
April 26, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., April 26, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) today announced the pricing of an underwritten public offering of 3,974,000 shares of newly issued common stock at a...
Avigen Reports First Quarter 2007 Financial Results
April 24, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., April 24, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, today...
Avigen to Present At CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
April 04, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., April 4, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions,...
Avigen Receives Approval to Initiate AV650 Phase II Clinical Development
March 14, 2007 08:00 ET
|
Avigen, Inc.
Avigen to Present at Cowen and Company Annual Health Care Conference
Webcast Scheduled for 9:30 a.m. (ET) on Thursday, March 15, 2007
ALAMEDA, Calif., March 14, 2007 (PRIME NEWSWIRE) --...
Avigen to Present at Cowen and Company Annual Health Care Conference
March 08, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., March 8, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions,...
Avigen to Present At Oppenheimer Pain Management Investor Conference
February 27, 2007 10:44 ET
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 27, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions,...
Avigen's AV411 Highlighted in Special Issue of Neuron Glia Biology
February 26, 2007 08:04 ET
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 26, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of neurological conditions, announced today...
Avigen Reports 2006 Financial Results and Reviews Clinical Progress
February 07, 2007 08:00 ET
|
Avigen, Inc.
Avigen to Discuss AV411 Safety and Tolerability Trial Results
ALAMEDA, Calif., Feb. 7, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) today reported financial results for fourth...